Related Experiment Video
Updated: Feb 13, 2026
07:10
Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
Published on: June 18, 2020
22.9K
Current therapy for hepatitis C: pegylated interferon and ribavirin
John G McHutchison1, Michael W Fried
1Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 27710, USA.
Clinics in Liver Disease
|April 15, 2003
Summary
Newer pegylated interferon and ribavirin treatments significantly improve sustained virological response for chronic hepatitis C. Understanding adherence and predictors is key for effective patient management.
Area of Science:
- Hepatology
- Virology
- Pharmacology
Background:
- Chronic hepatitis C is a significant global health concern.
- Standard interferon and ribavirin therapy has limitations in sustained virological response.
- Peginterferon alfa-2a and peginterferon alfa-2b represent advancements in treatment.
Purpose of the Study:
- To compare the efficacy of peginterferon alfa-2a/ribavirin and peginterferon alfa-2b/ribavirin against standard interferon/ribavirin.
- To review clinical trials evaluating these newer combination therapies.
- To identify factors influencing treatment response and adherence in chronic hepatitis C management.
Main Methods:
- Review of clinical trials comparing peginterferon alfa-2a/ribavirin and peginterferon alfa-2b/ribavirin with standard interferon/ribavirin.
- Analysis of sustained virological response rates.
- Evaluation of predictors of treatment outcome.
Main Results:
- Peginterferon alfa-2a/ribavirin and peginterferon alfa-2b/ribavirin demonstrate superior sustained virological response compared to standard therapy.
- These newer agents are the most effective initial treatments for chronic hepatitis C.
- Viral load, genotype, gender, age, and absence of fibrosis are consistent predictors of response.
Conclusions:
- Peginterferon alfa-2a/ribavirin and peginterferon alfa-2b/ribavirin are highly effective for initial chronic hepatitis C therapy.
- Predictability of response and treatment adherence are crucial for therapeutic success.
- Further research is needed to identify additional host immune and genetic factors influencing antiviral therapy outcomes.
More Related Videos
Related Concept Videos
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
255
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
255
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
281
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
281
01:21Hepatic Portal System
6.3K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
6.3K
00:59Gene Therapy
27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
01:10Electrical Current
7.2K
Electrical current is defined as the rate at which charge flows. When there is a large current present, such as that used to run a refrigerator, a large amount of charge moves through the wire in a small amount of time. If the current is small, such as that used to operate a handheld calculator, a small amount of charge moves through the circuit over a long period of time. The SI unit for current is the ampere (A), named for the French physicist André-Marie Ampère (1775–1836).
7.2K
01:26Group Therapy
469
Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
469